In this video, Brett Drummond (Co-Founder, MStranslate) and Dr Travis Stiles (CEO, Novoron Bioscience) discuss the latest research into remyelination for multiple sclerosis. In particular, they summarise data and share their opinions on positive and failed trials that were presented at ECTRIMS 2021, and answer community questions about this research.

If you have any questions about anything discussed during the video, please comment below and Travis and Brett will be more than happy to respond.

Learn more about MStranslate via the below links:

Website: https://mstranslate.com.au
Facebook:   / mstranslate  
Twitter:   / mstranslate  
Instagram:   / mstranslate  
LinkedIn:   / mstranslate